Sofinnova Investments as of Sept. 30, 2023
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 57 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 14.7 | $234M | 1.4M | 169.09 | |
| Natera (NTRA) | 8.7 | $137M | 3.1M | 44.25 | |
| AstraZeneca Sponsored Adr (AZN) | 5.8 | $92M | 1.4M | 67.72 | |
| Merck & Co (MRK) | 4.7 | $75M | 728k | 102.95 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 4.5 | $71M | 754k | 93.64 | |
| Rayzebio | 3.4 | $54M | 2.4M | 22.20 | |
| Dex (DXCM) | 3.2 | $51M | 550k | 93.30 | |
| Aerovate Therapeutics (AVTE) | 3.2 | $51M | 3.8M | 13.57 | |
| Intuitive Surgical (ISRG) | 3.2 | $51M | 173k | 292.29 | |
| Vera Therapeutics Cl A (VERA) | 3.0 | $48M | 3.5M | 13.71 | |
| Cytokinetics (CYTK) | 2.9 | $46M | 1.6M | 29.46 | |
| Elanco Animal Health (ELAN) | 2.6 | $41M | 3.6M | 11.24 | |
| IShares TR Russell 2000 Etf Put Option (IWM) | 2.5 | $40M | 225k | 176.74 | |
| argenx SE Sponsored Adr (ARGX) | 2.4 | $38M | 78k | 491.63 | |
| Exelixis Put Option (EXEL) | 2.4 | $38M | 1.7M | 21.85 | |
| Immatics NV SHS (IMTX) | 2.4 | $38M | 3.3M | 11.58 | |
| Sanofi Sponsored Adr (SNY) | 2.4 | $37M | 695k | 53.64 | |
| Kenvue (KVUE) | 2.3 | $36M | 1.8M | 20.08 | |
| IDEXX Laboratories (IDXX) | 2.1 | $34M | 78k | 437.27 | |
| ImmunoGen | 2.0 | $33M | 2.0M | 15.87 | |
| Syndax Pharmaceuticals Put Option (SNDX) | 1.8 | $29M | 2.0M | 14.52 | |
| Ideaya Biosciences (IDYA) | 1.8 | $28M | 1.0M | 26.98 | |
| Zentalis Pharmaceuticals (ZNTL) | 1.5 | $24M | 1.2M | 20.06 | |
| SPDR S&P 500 ETF Trust Tr Unit Put Option (SPY) | 1.3 | $21M | 50k | 427.48 | |
| Replimune Group Put Option (REPL) | 1.2 | $18M | 1.1M | 17.11 | |
| Inozyme Pharma (INZY) | 1.1 | $18M | 4.3M | 4.20 | |
| Invesco QQQ TR Unit Ser 1 | 1.1 | $18M | 50k | 358.27 | |
| Celldex Therapeutics (CLDX) | 1.1 | $17M | 624k | 27.52 | |
| Agenus Call Option (AGEN) | 1.1 | $17M | 15M | 1.13 | |
| MoonLake Immunotherapeutics Class A Ord (MLTX) | 1.1 | $17M | 293k | 57.00 | |
| Shockwave Med | 1.0 | $16M | 81k | 199.10 | |
| Alkermes SHS (ALKS) | 0.9 | $15M | 538k | 28.01 | |
| Inhibrx (INBX) | 0.9 | $14M | 743k | 18.35 | |
| Y Mabs Therapeutics (YMAB) | 0.8 | $12M | 2.2M | 5.45 | |
| Marinus Pharmaceuticals Call Option (MRNS) | 0.7 | $11M | 1.3M | 8.05 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.6 | $10M | 202k | 50.42 | |
| CRISPR Therapeutics Namen Akt Put Option (CRSP) | 0.6 | $9.1M | 200k | 45.39 | |
| Geron Corporation (GERN) | 0.5 | $7.8M | 3.7M | 2.12 | |
| Sarepta Therapeutics Call Option (SRPT) | 0.4 | $6.2M | 51k | 121.22 | |
| Dyne Therapeutics (DYN) | 0.4 | $6.1M | 685k | 8.96 | |
| Axsome Therapeutics (AXSM) | 0.4 | $5.6M | 80k | 69.89 | |
| Immunovant (IMVT) | 0.3 | $5.4M | 140k | 38.39 | |
| Nextcure (NXTC) | 0.2 | $3.4M | 2.7M | 1.29 | |
| Nucana Sponsored Adr (NCNA) | 0.2 | $3.4M | 5.6M | 0.61 | |
| Bolt Biotherapeutics (BOLT) | 0.2 | $2.9M | 2.8M | 1.04 | |
| Nucana Common Shares | 0.1 | $1.5M | 2.4M | 0.61 | |
| Immatics NV *w Exp 07/01/2025 (IMTXW) | 0.1 | $1.1M | 319k | 3.54 | |
| Stryker Corporation (SYK) | 0.1 | $896k | 3.3k | 273.27 | |
| Pds Biotechnology Ord (PDSB) | 0.0 | $720k | 143k | 5.05 | |
| Savara (SVRA) | 0.0 | $597k | 158k | 3.78 | |
| Galera Therapeutics (GRTX) | 0.0 | $540k | 3.1M | 0.18 | |
| Ikena Oncology (IKNA) | 0.0 | $501k | 116k | 4.33 | |
| Fusion Pharmaceuticals (FUSN) | 0.0 | $305k | 117k | 2.60 | |
| Mirum Pharmaceuticals (MIRM) | 0.0 | $287k | 9.1k | 31.60 | |
| Cymabay Therapeutics Put Option | 0.0 | $165k | 11k | 14.91 | |
| Spruce Biosciences (SPRB) | 0.0 | $131k | 58k | 2.26 | |
| Synlogic (SYBX) | 0.0 | $108k | 38k | 2.81 |
